Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05EKM
|
||||
Former ID |
DIB002600
|
||||
Drug Name |
FR-121196
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Terminated | [544870] | ||
Company |
Fujisawa Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H16FN3O3S
|
||||
Canonical SMILES |
S(=O)(=O)(NN1CCN(C(=O)C)CC1)c1ccc(cc1)F
|
||||
CAS Number |
CAS 133920-65-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 4 | Target Info | Modulator | [533791] | |
Somatostatin receptor type 2 | Target Info | Modulator | [533791] | ||
Somatostatin receptor type 3 | Target Info | Modulator | [530618], [532210] | ||
Somatostatin receptor type 5 | Target Info | Modulator | [533791] | ||
Somatostatin receptor 1 | Target Info | Modulator | [530618], [532210] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
References | |||||
Ref 530618 | Mol Endocrinol. 2010 Feb;24(2):436-46. Epub 2010 Jan 5.Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation. | ||||
Ref 532210 | Nat Rev Drug Discov. 2013 Feb;12(2):87-90. | ||||
Ref 533791 | Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer. Eur J Pharmacol. 1993 Sep 7;241(1):27-34. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.